Yubo International Financials
| YBGJ Stock | USD 0.07 0.0001 0.15% |
Yubo |
Understanding current and past Yubo International Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Yubo International's financial statements are interrelated, with each one affecting the others. For example, an increase in Yubo International's assets may result in an increase in income on the income statement.
Yubo International Stock Summary
Yubo International competes with InfuSystems Holdings, Repro Med, Nyxoah, Pro Dex, and ICU Medical. Yubo International Biotech Limited, thorough its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo Intl is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Building 5, Beijing, |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.yubogroup.com |
| Phone | 86 10 6615 5141 |
| Currency | USD - US Dollar |
Yubo International Key Financial Ratios
Yubo International's financial ratios allow both analysts and investors to convert raw data from Yubo International's financial statements into concise, actionable information that can be used to evaluate the performance of Yubo International over time and compare it to other companies across industries.| Return On Equity | -20.23 | |||
| Return On Asset | -0.26 | |||
| Number Of Employees | 20 | |||
| Beta | -2.88 |
Yubo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Yubo International's current stock value. Our valuation model uses many indicators to compare Yubo International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Yubo International competition to find correlations between indicators driving Yubo International's intrinsic value. More Info.Yubo International Biotech is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Yubo International's earnings, one of the primary drivers of an investment's value.Yubo International Systematic Risk
Yubo International's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Yubo International volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Yubo International correlated with the market. If Beta is less than 0 Yubo International generally moves in the opposite direction as compared to the market. If Yubo International Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Yubo International is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Yubo International is generally in the same direction as the market. If Beta > 1 Yubo International moves generally in the same direction as, but more than the movement of the benchmark.
Yubo International March 17, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Yubo International help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Yubo International Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Yubo International Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Yubo Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Yubo International's daily price indicators and compare them against related drivers.
| Downside Deviation | 11.12 | |||
| Information Ratio | 0.1123 | |||
| Maximum Drawdown | 52.75 | |||
| Value At Risk | (7.24) | |||
| Potential Upside | 12.18 |
Other Information on Investing in Yubo Pink Sheet
Yubo International financial ratios help investors to determine whether Yubo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yubo with respect to the benefits of owning Yubo International security.